Table 1

Clinical features of the clinically examined participants with NT-proBNP ≥900 ng/L

Female, n (%)49 (53)
BMI, median (Q1–Q3)24.8 (23.2–27.5)
NT-proBNP, median (Q1–Q3)1200 (1000–1750)
New diagnosis of AF, n (%)28 (30)
Hypertension, n (%)69 (74)
Diabetes mellitus, n (%)21 (22.6)
Vascular disease*, n (%)19 (20.4)
 Previous AMI, n (%)11 (11.8)
History of ischaemic stroke/TIA11 (11.8)
Glomerular filtration rate, mL/min, median (Q1–Q3)64 (38–74)
Glomerular filtration rate <60 mL/min, n (%)41 (44)
  • *Previous AMI (Acute Myocardial Infarction), CABG (Coronary By-Pass Surgery) or PCI.(Percutanous Coronary Intervention)

  • AMI, acute myocardial infarctio; BMI, body mass index; CABG, coronary by-pass surgery; NT-proBNP, N-terminal pro-type-B natriuretic peptide; PCI, percutaneous coronary intervention; Q1, first quartile; Q3, third quartile; TIA, transitory ischaemic attack.